Integrated Research Limited provided revenue guidance for the full year 2023. Subject to audit, the company expected the TCV result to translate into reported statutory revenue in the range of $39 million - $42 million for the period, an increase of 1% - 9% on the pcp. On a pro-forma basis, revenue is anticipated to be in the range of $36 million - $38 million, down -6% - 0% on the pcp, reflecting lower recurring (licence) revenue.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 AUD | -4.46% | +21.95% | +108.33% |
May. 10 | Integrated Research's Shares Surge More Than 50% on Upbeat Guidance | MT |
Mar. 06 | Cathy Aston Resigns as Director of Integrated Research Limited, Effective 31 March 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+108.33% | 91.6M | |
+12.51% | 3,144B | |
+12.68% | 88.51B | |
-13.71% | 54.56B | |
+26.21% | 48.26B | |
-22.56% | 47.95B | |
+25.42% | 44.14B | |
+69.48% | 39.42B | |
-8.00% | 25.26B | |
+26.00% | 23.15B |
- Stock Market
- Equities
- IRI Stock
- News Integrated Research Limited
- Integrated Research Limited Provides Revenue Guidance for the Full Year 2023